西班牙瓦伦西亚地区女性人乳头瘤病毒疫苗对生殖器疣的效果
基于西班牙瓦伦西亚社区2009年1月至2014年12月14–19岁女性健康数据库的人群研究(n=279,787),共发生612例生殖器疣,总发病率为75.8/10万人年(95% CrI 69.7–81.8)。四价HPV疫苗三剂方案效果为77%(95% CrI 66–85%),单剂为61%(95% CrI 20–87%),二价疫苗全程接种未见效果。
要点
- 四价HPV疫苗三剂方案对生殖器疣的效果为77%(95% CrI 66–85%)。
- 四价HPV疫苗单剂效果为61%(95% CrI 20–87%)。
- 二价HPV疫苗全程接种未见效果。
核心结论
- 在我们的人群中,三剂四价HPV疫苗对生殖器疣有效。
- 在疫苗覆盖率低的情况下,生殖器疣发病率仅在已接种者中下降。
研究设计与样本
- 基于健康数据库的人群研究,纳入2009年1月至2014年12月在瓦伦西亚社区登记的所有14–19岁女孩和女性(n=279,787)。
- 生殖器疣事件病例定义为研究期间在初级保健和门诊诊所首次激活诊断代码ICD-9-CM 078.11(尖锐湿疣)。
主要发现
- 共发生612例生殖器疣,总发病率为75.8/10万人年(95% CrI 69.7–81.8)。
- 与往年相比,当四价HPV疫苗的女性接种候选者在2012年达到18岁时,生殖器疣发病率出现下降。
- 未接种女性及接种二价疫苗者的生殖器疣发病率高于接种四价HPV疫苗的女孩和女性。
关键数值与推荐
- 四价HPV疫苗三剂方案的效果为77%(95% CrI 66–85%)。
- 四价HPV疫苗单剂的效果为61%(95% CrI 20–87%)。
- 二价HPV疫苗全程接种未见效果。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the effectiveness of the HPV vaccines in preventing genital warts in young women. DESIGN: Population-based study using health databases. SETTING: Valencian Community (Spain). PARTICIPANTS: All girls and women aged 14-19years who were registered in the Valencian Community between January 2009 and December 2014 (n=279,787). MAIN OUTCOME MEASURES: Incident cases of genital warts were defined as the first activation of diagnosis code ICD-9-CM 078.11 (Condyloma acuminatum) in primary care and outpatient clinics during the study period. RESULTS: There were 612 cases of genital warts. The overall incidence rate was 75.8/100,000 person-years (95% CrI 69.7-81.8). There was a decrease in genital warts when female candidates to be vaccinated with quadrivalent HPV vaccine reached the age of 18 (in 2012), compared to previous years. Incidence of genital warts in unvaccinated women and those who received the bivalent vaccine was higher than in girls and women who received the quadrivalent HPV vaccine. The effectiveness of a three-dose regimen of the quadrivalent HPV vaccine was 77% (95 CrI: 66-85%), whereas that of a single dose was 61% (95 CrI: 20-87%). No effectiveness was seen with a full vaccination course with the bivalent HPV vaccine. CONCLUSIONS: Three doses of the quadrivalent HPV vaccine were effective against genital warts in our population. Moreover, with low vaccine coverage the incidence of genital warts decreased only in the vaccinated.
引用
- Navarro-Illana E, López-Lacort M, Navarro-Illana P, et al. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain. Vaccine. 2017. PMID: 28499554. doi:10.1016/j.vaccine.2017.04.080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。